Lasa Supergenerics Limited is a company based in Ratnagiri, India that specializes in the research, manufacturing, and marketing of animal and human healthcare products. Its product portfolio includes a range of API products such as fenbendazole, toldimphos sodium, cyromazine, albendazole, riclabendazole, rafoxanide, ornidazole, ricobendazole, oxfendazole, closantel base, closantel sodium, nitroxynil, halquinol, and oxyclozanide, as well as 2,6-diiodo-4-nitrophenol and other API products. Additionally, the company offers animal feed ingredients like calcium iodate and therapeutic reagents such as potassium iodide. Lasa Supergenerics Limited, established in 2016, also exports its products.
Navigation section
Lasa Supergenerics Limited
- 27.80 1.22(4.59%) 27.75 1.21(4.56%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 26.58 26.91 | 27.90 27.86 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 19.00 (05-Jun-2024) 19.00 (05-Jun-2024) | 41.20 (09-Jan-2024) 40.95 (09-Jan-2024) |
- Open
- 27.89 27.86
- Previous Close
- 26.58 26.54
- Volume
- 1.09
- Total Traded value
- 0.30 (₹ Lakhs)
- Upper circuit
- 27.90 36.61
- Lower circuit
- 25.25 33.13
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 4,743 | 0 |
| Bid Price | Quantity |
|---|---|
| 27.51 | 4,743.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 4,743 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹1.39 Cr |
| PE Ratio (TTM): | -5.85 |
| PB Ratio: | 1.38 |
| Industry P/E: | 0.00 |
| Debt to Equity: | - |
| ROE: | -23.50 |
| EPS (TTM): | -4.53 |
| Book Value: | 22.62 |
| Face Value: | 10.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 24.30 Cr | 30.56 Cr | 35.32 Cr | 31.70 Cr | 33.66 Cr |
| Profit | -0.02 Cr | -4.95 Cr | -15.00 Cr | -4.92 Cr | -6.61 Cr |
| Expense | 26.50 Cr | 29.53 Cr | 35.57 Cr | 37.69 Cr | 37.94 Cr |
| Comprehensive income | -0.02 Cr | -4.95 Cr | -14.96 Cr | -4.92 Cr | -6.61 Cr |
| EPS | 0.00 | -0.99 | -5.98 | -1.21 | -1.62 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Lasa Supergenerics Limited | Sep, 2017 Sep, 2017 | Pharmaceuticals Pharmaceuticals | LASA LASA |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Jan, 2023 Dec, 2022
Lasa Supergenerics Limited FAQ's
What is the range of today's stock performance for Lasa Supergenerics Limited?
Today's stock performance witnessed a fluctuation from a minimum of 26.58 on the NSE (National Stock Exchange) to a maximum of 27.90. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 26.91 to a high of 27.86.
What are the 52-week low and high values for Lasa Supergenerics Limited?
The stock's performance over the past 52 weeks reveals a low of 19.00 (occurred on 05-Jun-2024) and a high of 41.20 (achieved on 09-Jan-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 19.00 (on 05-Jun-2024), and the 52-week high is 40.95 (on 09-Jan-2024).
What was the opening and previous closing prices for Lasa Supergenerics Limited?
The stock's performance over the past 52 weeks reveals a low of 19.00 (occurred on 05-Jun-2024) and a high of 41.20 (achieved on 09-Jan-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 19.00 (on 05-Jun-2024), and the 52-week high is 40.95 (on 09-Jan-2024).
What is the total volume and traded value for Lasa Supergenerics Limited for the day?
The total volume is 1, and the total traded value is 0.30 (₹ Lakhs).
What are the upper and lower circuit limits for Lasa Supergenerics Limited?
The upper circuit limit is 27.90, and the lower circuit limit is 25.25.
What is the market cap and PE ratio for Lasa Supergenerics Limited?
The market cap is ₹1.39 Cr, and the PE ratio (TTM) is 0.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Lasa Supergenerics Limited?
The PB ratio is 1.23, industry P/E is 0.00 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Lasa Supergenerics Limited?
ROE is -23.50, EPS is -4.53, book value is 22.62
What are the revenue and profit figures for the latest quarter and previous quarters for Lasa Supergenerics Limited?
In Sep 2023, Revenue is ₹243026000.00, and Profit is ₹-229000.00. In Jun 2023, Revenue is ₹305560000.00, and Profit is ₹-49495000.00.
When was Lasa Supergenerics Limited listed, and what industry does it belong to?
The company, Lasa Supergenerics Limited, was listed in Sep 2017 and belongs to the Pharmaceuticals industry. Its NSE symbol is LASA.
What is the current shareholding pattern of the Lasa Supergenerics Limited?
As of latest available update, promoters hold 53.65%, the public holds 46.35%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 94
